Thursday, 24 March 2016

Novartis Agrees To SEC Settlement

The company will pay about $25 million in a settlement with the Securities and Exchange Commission related to bookkeeping failures. Bristol-Myers-Squib will acquire a privately held company that will move it into the auto-immune disease drug market, and Propeller Health enters a digital partnership. News outlets also provide the latest on biosimilars and blood thinners,

No comments:

Post a Comment